http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9423706-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c352730fd6b1c029cbd7080e8ae5cf8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1275 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate | 1994-04-20^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a0af5fb0a38e4224bf7961e80cced2 |
| publicationDate | 1994-10-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9423706-A1 |
| titleOfInvention | Foam cell drug delivery |
| abstract | Methods and pharmaceutical compositions for delivering a clinically relevant agent to a mammalian recipient in vivo are provided. The methods involve forming a foam cell from an isolated foam cell precursor in vitro, incorporating an agent into the foam cell, and administering the foam cell containing the agent to the mammalian recipient. In a preferred embodiment, the foam cell precursors are isolated from a human recipient, treated, and returned to the patient in the form of a foam cell containing a therapeutically effective amount of the agent. |
| priorityDate | 1993-04-20^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 692 of 692.